Marcus Unterrainer Selected Research

Marcus Unterrainer Research Topics

Disease

30	Neoplasms (Cancer) 11/2023 - 01/2016
24	Glioma (Gliomas) 05/2023 - 01/2016
13	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 10/2017
10	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 01/2016
8	Meningioma (Meningiomas) 11/2023 - 10/2017
8	Neoplasm Metastasis (Metastasis) 11/2021 - 01/2017
6	Neuroinflammatory Diseases 06/2022 - 10/2017
5	Lymphoma (Lymphomas) 10/2023 - 01/2022
4	Brain Neoplasms (Brain Tumor) 01/2021 - 10/2016
3	Carcinoma (Carcinomatosis) 01/2024 - 11/2020
3	Disease Progression 02/2021 - 01/2019
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2023 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 07/2022
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 03/2020
2	Lymphatic Metastasis 01/2023 - 11/2020
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 05/2021
2	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 01/2021
2	Melanoma (Melanoma, Malignant) 12/2022 - 05/2021
2	Progressive Multifocal Leukoencephalopathy 06/2022 - 10/2021
2	Multiple Sclerosis 10/2021 - 10/2017
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2021 - 01/2021
2	follicular Thyroid cancer 02/2021 - 10/2017
2	Amyloidosis 01/2021 - 12/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 11/2015
2	Corticobasal Degeneration 01/2021 - 01/2021
2	Dementia (Dementias) 01/2020 - 12/2017
2	Gliosarcoma 11/2019 - 11/2017
2	Neurosarcoidosis 01/2019 - 11/2018
2	Relapsing-Remitting Multiple Sclerosis 01/2018 - 10/2017
1	Penile Neoplasms (Penile Cancer) 05/2024
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024
1	Cytokine Release Syndrome 10/2023
1	cell-associated neurotoxicity 10/2023
1	Cerebellar Ataxia (Dysmetria) 01/2023
1	Ataxia (Dyssynergia) 01/2023
1	Adenocarcinoma 01/2023
1	Cerebellar Diseases (Cerebellar Syndrome) 01/2023
1	Nervous System Diseases (Neurological Disorders) 01/2023
1	Urogenital Neoplasms 01/2023
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2023
1	Lung Neoplasms (Lung Cancer) 11/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Infections 10/2021
1	Inflammation (Inflammations) 10/2021

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2017
11	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2018
8	AntigensIBA 12/2023 - 11/2017
8	LigandsIBA 01/2023 - 10/2017
8	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2022 - 01/2019
7	Amino Acids FDA Link 02/2023 - 01/2017
6	Chimeric Antigen ReceptorsIBA 10/2023 - 01/2022
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2023 - 01/2018
5	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2023 - 04/2018
4	Tyrosine (L-Tyrosine)FDA Link 01/2024 - 01/2019
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2020
4	thiamine triphosphorate (TTP)IBA 01/2023 - 09/2018
4	gallium Ga 68 dotatateIBA 03/2019 - 10/2017
3	Peptides (Polypeptides)IBA 11/2023 - 08/2021
3	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2023 - 01/2021
3	Amyloid (Amyloid Fibrils)IBA 01/2021 - 12/2017
2	salicylhydroxamic acid (SHAM)IBA 01/2024 - 01/2021
2	Temozolomide (Temodar)FDA LinkGeneric 10/2023 - 09/2018
2	durvalumabIBA 01/2023 - 07/2022
2	Indicators and Reagents (Reagents)IBA 10/2022 - 11/2019
2	PSMA I&TIBA 04/2022 - 10/2021
2	Amino Acid Transport Systems (Amino Acid Transporter)IBA 12/2021 - 11/2018
2	gallium 68 PSMA-11IBA 11/2021 - 10/2017
2	IodineIBA 02/2021 - 01/2021
2	RacivirIBA 02/2021 - 01/2021
2	GadoliniumIBA 01/2019 - 09/2018
1	Radioisotopes (Radionuclides)IBA 11/2023
1	MethyltransferasesIBA 10/2023
1	DNA (Deoxyribonucleic Acid)IBA 10/2023
1	Immune Checkpoint InhibitorsIBA 06/2023
1	177Lu-PSMA-617IBA 01/2023
1	acetylleucineIBA 01/2023
1	68Ga-FAPIIBA 01/2023
1	NivolumabIBA 12/2022
1	IpilimumabIBA 12/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2022
1	PlatinumIBA 07/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Rituximab (Mabthera)FDA Link 10/2021
1	Natalizumab (Tysabri)FDA Link 10/2021

Therapy/Procedure

32	Therapeutics 05/2024 - 01/2016
10	Radiotherapy 10/2023 - 10/2016
5	Precision Medicine 11/2023 - 11/2017
4	Prostatectomy (Retropubic Prostatectomy) 12/2023 - 11/2021
4	Re-Irradiation 05/2023 - 01/2017
4	Chemoradiotherapy 01/2023 - 01/2021
4	Drug Therapy (Chemotherapy) 11/2022 - 09/2018
3	Castration 01/2023 - 10/2021
3	Immunotherapy 12/2022 - 05/2021
3	Combined Modality Therapy 11/2022 - 07/2018
2	Lymph Node Excision (Lymph Node Dissection) 12/2023 - 11/2021
2	Thyroidectomy 11/2020 - 10/2017
1	Cystectomy 01/2024
1	Immunomodulation 05/2023
1	Brachytherapy 01/2022